PH25503A - Method of medical treatment - Google Patents

Method of medical treatment

Info

Publication number
PH25503A
PH25503A PH36241A PH36241A PH25503A PH 25503 A PH25503 A PH 25503A PH 36241 A PH36241 A PH 36241A PH 36241 A PH36241 A PH 36241A PH 25503 A PH25503 A PH 25503A
Authority
PH
Philippines
Prior art keywords
medical treatment
methyl
treatment
carbazol
imidazol
Prior art date
Application number
PH36241A
Other languages
English (en)
Inventor
Michael Brian Tyers
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PH25503A publication Critical patent/PH25503A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Emergency Protection Circuit Devices (AREA)
  • Connection Of Batteries Or Terminals (AREA)
  • Saccharide Compounds (AREA)
  • Electrotherapy Devices (AREA)
PH36241A 1986-12-17 1987-12-16 Method of medical treatment PH25503A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868630071A GB8630071D0 (en) 1986-12-17 1986-12-17 Medicaments

Publications (1)

Publication Number Publication Date
PH25503A true PH25503A (en) 1991-07-24

Family

ID=10609112

Family Applications (1)

Application Number Title Priority Date Filing Date
PH36241A PH25503A (en) 1986-12-17 1987-12-16 Method of medical treatment

Country Status (18)

Country Link
US (1) US4835173A (cs)
EP (1) EP0276559B1 (cs)
JP (1) JP2732844B2 (cs)
KR (1) KR880007073A (cs)
AT (1) ATE79031T1 (cs)
AU (1) AU608794B2 (cs)
CY (1) CY1693A (cs)
DE (1) DE3780940T2 (cs)
DK (1) DK662787A (cs)
ES (1) ES2051754T3 (cs)
GB (1) GB8630071D0 (cs)
GR (1) GR3005682T3 (cs)
HK (1) HK36593A (cs)
IE (1) IE60135B1 (cs)
IL (1) IL84844A0 (cs)
NZ (1) NZ222949A (cs)
PH (1) PH25503A (cs)
ZA (1) ZA879458B (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5246941A (en) 1986-12-17 1993-09-21 Glaxo Group Limited Method for the treatment of depression
US4973594A (en) * 1986-12-17 1990-11-27 Glaxo Group Limited Medicaments
GB8820653D0 (en) * 1988-09-01 1988-10-05 Glaxo Group Ltd Medicaments
US5221687A (en) * 1988-09-01 1993-06-22 Glaxo Group Limited Medicaments
US5180728A (en) * 1989-09-25 1993-01-19 Fujisawa Pharmaceutical Company, Ltd. Pyrimidoindole derivatives and processes for preparation thereof
US5225407A (en) * 1990-02-22 1993-07-06 Glaxo Group Limited 5-HT3 receptor antagonists for the treatment of autism
EP0591434A4 (en) * 1991-06-26 1994-09-14 Sepracor Inc Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron
US6548082B1 (en) 1999-03-01 2003-04-15 Sepracor Inc. Methods for treating apnea and apnea disorders using optically pure R(+) ondansetron
EP1339707A2 (en) * 2000-10-30 2003-09-03 Teva Pharmaceutical Industries Ltd. Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation
EP1207160A1 (en) * 2000-11-20 2002-05-22 Hanmi Pharm. Co., Ltd. Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one
US20020115707A1 (en) * 2001-01-11 2002-08-22 Rami Lidor-Hadas Process for preparing pure ondansetron hydrochloride dihydrate
HUP0400767A2 (hu) * 2001-01-11 2004-07-28 Teva Pharmaceutical Industries Limited Javított eljárás tiszta ondansetron-hidroklorid-dihidrát előállítására
CN1665823A (zh) 2002-04-29 2005-09-07 特瓦药厂有限公司 制备1,2,3,9－四氢－9－甲基－3－[(2－甲基－1h－咪唑－1－基)甲基]－4h－咔唑－4－酮的方法
DE20320528U1 (de) * 2002-04-30 2004-09-16 Teva Pharmaceuticals Usa, Inc. Neue Kristallformen von Ondansetron und Arzneimittel, welche die neuen Formen enthalten
US20050131045A1 (en) * 2002-04-30 2005-06-16 Judith Aronhime Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them
HU225885B1 (en) * 2002-10-17 2007-11-28 Richter Gedeon Nyrt Process for producing ondansetron hydrochlorid dihydrate of high purity
US20110034442A1 (en) * 2007-08-08 2011-02-10 Jaun Jose Legarda Ibanez Use and Methods of Use for an Antagonist of the Serotin3 Receptor (5-HT3) and a Selective Modulator of Chloride Channels for the Treatment of Addiction to or Dependence on Medicines/Drugs or Nervous System Disorders
EP3810119A2 (en) 2018-06-21 2021-04-28 Société des Produits Nestlé S.A. <sup2/>? <sub2/>?+? ?compositions and methods using a nicotinamide adenine dinucleotide (nad) precursor and at least one ketone or ketone precursor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN158970B (cs) * 1981-06-09 1987-02-28 Ici Plc
GR850219B (cs) * 1984-01-25 1985-05-23 Glaxo Group Ltd
GB8401888D0 (en) * 1984-01-25 1984-02-29 Glaxo Group Ltd Heterocyclic compounds
DE3688296T2 (de) * 1985-03-14 1993-11-04 Beecham Group Plc Arzneimittel zur behandlung von erbrechen.
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
NL8701682A (nl) * 1986-07-30 1988-02-16 Sandoz Ag Werkwijze voor het therapeutisch toepassen van serotonine antagonisten, aktieve verbindingen en farmaceutische preparaten die deze verbindingen bevatten.

Also Published As

Publication number Publication date
JPS63165314A (ja) 1988-07-08
EP0276559A3 (en) 1989-10-18
DE3780940T2 (de) 1992-12-24
AU608794B2 (en) 1991-04-18
IE873415L (en) 1988-06-17
CY1693A (en) 1994-01-14
HK36593A (en) 1993-04-23
DK662787D0 (da) 1987-12-16
DK662787A (da) 1988-06-18
EP0276559A2 (en) 1988-08-03
GR3005682T3 (cs) 1993-06-07
ZA879458B (en) 1988-11-30
AU8261787A (en) 1988-06-23
JP2732844B2 (ja) 1998-03-30
ES2051754T3 (es) 1994-07-01
DE3780940D1 (de) 1992-09-10
GB8630071D0 (en) 1987-01-28
KR880007073A (ko) 1988-08-26
US4835173A (en) 1989-05-30
NZ222949A (en) 1997-06-24
ATE79031T1 (de) 1992-08-15
IL84844A0 (en) 1988-06-30
IE60135B1 (en) 1994-06-01
EP0276559B1 (en) 1992-08-05

Similar Documents

Publication Publication Date Title
PH25503A (en) Method of medical treatment
SE8503680L (sv) Indolderivat
HU9502193D0 (en) Combination treatment for inhibiting bone loss
AU1808488A (en) Compounds for the treatment of alzheimer&#39;s disease
IE873414L (en) Medicament for dementia
IT1238825B (it) Dispositivo per la correzione chirurgica dell&#39;ametropia.
GR3004252T3 (cs)
HU902004D0 (en) New trombolitic preparations
IT8722772A0 (it) Protesi ortopedica, particolarmente per la testa del femore.
IE873231L (en) Medicaments
GR3005231T3 (cs)
EP1263495A4 (en) CANNULATION SYSTEM RELATED METHODS
李虎容 et al. OCCLUSAL CONSIDERATION FOR IMPLANTS
TW217382B (cs)
GB8600666D0 (en) Apparatus for surgical &amp; medical uses
IT8919216A0 (it) Dispositivo per la cura chirurgica dell&#39;astigmatismo.
CS754186A1 (en) Aid for medical instruments&#39; introduction
FI882378A7 (fi) Tandlaekarens patientstol.
IT1216064B (it) Procedimento per il riempimento e/o l&#39;otturazione in interventi chirurgici e odontoiatrici.
GEP19991579B (en) Method for Shunting of Arteries
PL54844Y1 (en) Dental surgeon&#39;s syringe